Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care

Download All
In this online program centered around a dynamic CCO symposium in Orlando, experts discuss recent advances in the management of essential thrombocythemia, polycythemia vera, and myelofibrosis. Watch the on-demand Webcast and download the slides from the symposium and read expert commentaries on current and emerging therapeutic strategies for patients with MPNs.
Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD
Raajit K. Rampal, MD, PhD
Alessandro M. Vannucchi, MD
Srdan Verstovsek, MD, PhD

On-Demand Webcast

Watch this CME-certified on-demand Webcast of a CCO live symposium from ASH 2019 to gain insights from the experts on best practices for the individualized care of patients with myeloproliferative neoplasms.

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Physicians: maximum of 2.5 AMA PRA Category 1 Credits Released: January 17, 2020 Expired: No longer available for credit

ClinicalThought

Outcomes are poor for patients with myelofibrosis who discontinue ruxolitinib due to loss of response or intolerance. In this commentary, I offer my thoughts on the best treatment options for these patients.

Srdan Verstovsek, MD, PhD Released: October 7, 2019

In this commentary, Raajit K. Rampal, MD, PhD, highlights key MPN studies that will be presented at the upcoming 2019 ASH annual meeting in Orlando.

Raajit K. Rampal, MD, PhD Released: December 2, 2019

Read expert answers to key questions from the audience at a recent symposium on optimal management of patients with myeloproliferative neoplasms.

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Released: January 16, 2020

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices on diagnosis, driver mutations, and risk stratification for patients with MPNs.

Alessandro M. Vannucchi, MD Released: December 6, 2019

Download this slideset for expert perspectives on current best practices on managing patients with myelofibrosis.

Srdan Verstovsek, MD, PhD Released: December 6, 2019

Download this slideset for expert perspectives on emerging therapies and optimal management of patients with myelofibrosis that is intolerant/resistant to ruxolitinib.

Raajit K. Rampal, MD, PhD Released: December 6, 2019

Download this slideset for expert perspectives on best practice for managing patients with PV and ET.

Jean-Jacques Kiladjian, MD, PhD Released: December 6, 2019
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Celgene Corporation
CTI Biopharma
Geron Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings